Indian pharma group to produce 200 million doses of Russia's Sputnik V: maker
Indian pharma group to produce 200 million doses of Russia's Sputnik V: maker
MOSCOW (AFP) - The maker of Russia s Sputnik V coronavirus vaccine said Monday it had signed an agreement with an India-based pharmaceuticals giant for the production of up to 200 million doses of the jab a year.
The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a statement it partnered with the Virchow Group to produce up to 200 million doses of Sputnik a year in India.
